Saturday, August 27, 2016

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

Friday, August 26, 2016

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

DMEMEDS shared post via Reuters: Lilly says drug slows Alzheimer's in patients with mild disease

(Reuters) - Patients with mild Alzheimer's disease who took Eli Lilly and Co's experimental drug solanezumab early in the course of their disease preserved more of their cognitive and functional ability, according to new Lilly data released on Wednesday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/uJVHBjvU_tc/story01.htm

Read More

DMEMEDS shared post via ABC: Experts Puzzled by Teen???s 12-Year HIV Remission Without Drugs

Teen reportedly has been able to stay off HIV medication for at least 12 years. [Category: Health] http://abcnews.go.com/Health/teen-stays-hiv-remission-12-years-drugs-researchers/story?id=32593674

Read More

DMEMEDS shared post via Reuters: Heart device maker St. Jude to buy Thoratec for $3.4 billion

(Reuters) - St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/A40vNGKEcqA/story01.htm

Read More

DMEMEDS shared post via ABC: Teen Explains What Life is Like in a Coma

Teen with cystic fibrosis describes life in a coma. [Category: Health] http://abcnews.go.com/Health/teen-explains-life-coma/story?id=32473542

Read More

DMEMEDS shared post via Reuters: AstraZeneca suffers setback as drug fails in eye cancer

LONDON (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a modest blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for a rare cancer of the eye. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/D1o8CnqxgIg/story01.htm

Read More

Subscribe Now: Feed Icon